UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Long-term follow-up of an alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant (RIT) regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL)

Morris, E; Thomson, K; Craddock, C; Milligan, D; Smith, G; Parker, A; Schey, S; ... Mackinnon, S; + view all (2004) Long-term follow-up of an alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant (RIT) regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 29 - 29). BLACKWELL PUBLISHING LTD

Full text not available from this repository.
Type: Proceedings paper
Title: Long-term follow-up of an alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant (RIT) regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL)
Event: Annual Scientific Meeting of the British-Society-for-Haematology
Location: Cardiff, WALES
Dates: 2004-04-19 - 2004-04-21
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: http://discovery.ucl.ac.uk/id/eprint/171807
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item